35 related articles for article (PubMed ID: 20978316)
1. Snake venom toxin from Vipera lebetina turanica induces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expression.
Park MH; Jo M; Won D; Song HS; Han SB; Song MJ; Hong JT
BMC Cancer; 2012 Jun; 12():228. PubMed ID: 22681760
[TBL] [Abstract][Full Text] [Related]
2. Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax.
Gupta SC; Reuter S; Phromnoi K; Park B; Hema PS; Nair M; Aggarwal BB
J Biol Chem; 2011 Jan; 286(2):1134-46. PubMed ID: 21078664
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors.
Shoeb M; Ramana KV; Srivastava SK
Free Radic Biol Med; 2013 Oct; 63():280-90. PubMed ID: 23732517
[TBL] [Abstract][Full Text] [Related]
4. IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas.
Wang Q; Zhang Y; Zhu J; Zheng H; Chen S; Chen L; Yang HS
Signal Transduct Target Ther; 2020 Aug; 5(1):153. PubMed ID: 32843616
[TBL] [Abstract][Full Text] [Related]
5. A novel caspase 8 selective small molecule potentiates TRAIL-induced cell death.
Bucur O; Gaidos G; Yatawara A; Pennarun B; Rupasinghe C; Roux J; Andrei S; Guo B; Panaitiu A; Pellegrini M; Mierke DF; Khosravi-Far R
Sci Rep; 2015 May; 5():9893. PubMed ID: 25962125
[TBL] [Abstract][Full Text] [Related]
6. A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal.
Janku F; Huang HJ; Angelo LS; Kurzrock R
Oncotarget; 2013 Mar; 4(3):463-73. PubMed ID: 23531874
[TBL] [Abstract][Full Text] [Related]
7. TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.
Guerrache A; Micheau O
Cells; 2024 Mar; 13(6):. PubMed ID: 38534365
[TBL] [Abstract][Full Text] [Related]
8. RETRACTED: Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression.
Lin T; Ding Z; Li N; Xu J; Luo G; Liu J; Shen J
Eur J Cancer; 2011 Aug; 47(12):1890-907. PubMed ID: 21565489
[TBL] [Abstract][Full Text] [Related]
9. Noncompetitive Allosteric Antagonism of Death Receptor 5 by a Synthetic Affibody Ligand.
Vunnam N; Szymonski S; Hirsova P; Gores GJ; Sachs JN; Hackel BJ
Biochemistry; 2020 Oct; 59(40):3856-3868. PubMed ID: 32941010
[TBL] [Abstract][Full Text] [Related]
10. Daurisoline inhibits proliferation, induces apoptosis, and enhances TRAIL sensitivity of breast cancer cells by upregulating DR5.
Liu X; Wang LL; Duan CY; Rong YR; Liang YQ; Zhu QX; Hao GP; Wang FZ
Cell Biol Int; 2024 Apr; ():. PubMed ID: 38563483
[TBL] [Abstract][Full Text] [Related]
11. DR5 disulfide bonding as a sensor and effector of protein folding stress.
Law ME; Dulloo ZM; Eggleston SR; Takacs GP; Alexandrow GM; Wang M; Su H; Forsyth B; Chiang CW; Sharma A; Kanumuri SRR; Guryanova OA; Harrison JK; Tirosh B; Castellano RK; Law BK
bioRxiv; 2024 Mar; ():. PubMed ID: 38496520
[TBL] [Abstract][Full Text] [Related]
12. Death Receptors: New Opportunities in Cancer Therapy.
Ukrainskaya VM; Stepanov AV; Glagoleva IS; Knorre VD; Belogurov AAJ; Gabibov AG
Acta Naturae; 2017; 9(3):55-63. PubMed ID: 29104776
[TBL] [Abstract][Full Text] [Related]
13. A Novel High-Throughput Technique for Identifying Monoclonal Antibodies Capable of Death Receptor Induced Apoptosis.
Kwok HF; Gormley JA; Scott CJ; Johnston JA; Olwill SA
J Cell Death; 2009; 2():45-51. PubMed ID: 26124680
[TBL] [Abstract][Full Text] [Related]
14. A phase separation-fortified bi-specific adaptor for conditional tumor killing.
Liu Y; Zhu Y; Xu W; Li P
Sci China Life Sci; 2024 Mar; ():. PubMed ID: 38561483
[TBL] [Abstract][Full Text] [Related]
15. IGF‑1 inhibits palmitic acid‑induced mitochondrial apoptosis in macrophages.
Tang W; Zhang M; Wang Y; Ma D; Hu M; Zhang Y; Lin H; Jiang W; Ouyang Y; Jiang L; He P; Zhao G; Ouyang X
Mol Med Rep; 2023 Dec; 28(6):. PubMed ID: 37921069
[TBL] [Abstract][Full Text] [Related]
16. Switching off key signaling survival molecules to switch on the resolution of inflammation.
Perez DA; Vago JP; Athayde RM; Reis AC; Teixeira MM; Sousa LP; Pinho V
Mediators Inflamm; 2014; 2014():829851. PubMed ID: 25136148
[TBL] [Abstract][Full Text] [Related]
17. Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.
van Geelen CM; Pennarun B; Le PT; de Vries EG; de Jong S
BMC Cancer; 2011 Jan; 11():39. PubMed ID: 21272366
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL.
Pennarun B; Kleibeuker JH; Oenema T; Stegehuis JH; de Vries EG; de Jong S
Anal Cell Pathol (Amst); 2010; 33(5):229-44. PubMed ID: 20978316
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL.
Pennarun B; Kleibeuker JH; Oenema T; Stegehuis JH; de Vries EG; de Jong S
Cell Oncol (Dordr); 2011 Jun; 34(3):245-59. PubMed ID: 21538027
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
